We are live on ! Find out more
CYNA

CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA

Delisted

CYNA was delisted on the 20th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 60 → 0 (-60)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $348M → $0 (-$348M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 60

Holders
–
Holders Change
-60
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$45.1M
2
BHMP
Bardin Hill Management Partners
New York
-$24M
3
CC
Coastland Capital
California
-$21.3M
4
WIC
Water Island Capital
New York
-$20.8M
5
FCM
Farallon Capital Management
California
-$20.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAC
26
OMERS Administration Corp
Ontario, Canada
– -$3.77M -93,600 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$3.51M -87,300 Closed
KAM
28
Kassirer Asset Management
Ontario, Canada
– -$3.22M -80,000 Closed
GF
29
Gabelli Funds
New York
– -$3.2M -79,500 Closed
WRBC
30
W.R. Berkley Corp
Connecticut
– -$2.71M -67,410 Closed
SCM
31
Segantii Capital Management
Hong Kong
– -$2.12M -52,554 Closed
SCM
32
Stevens Capital Management
Pennsylvania
– -$2.08M -51,590 Closed
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
– -$2.01M -50,000 Closed
Deutsche Bank
34
Deutsche Bank
Germany
– -$1.98M -49,100 Closed
Ameriprise
35
Ameriprise
Minnesota
– -$1.96M -48,728 Closed
HA
36
Havens Advisors
New York
– -$1.91M -47,500 Closed
AGM
37
Alpine Global Management
New York
– -$1.73M -42,886 Closed
GI
38
GAMCO Investors
Connecticut
– -$1.4M -34,825 Closed
AL
39
Airain Ltd
Guernsey
– -$1.17M -29,000 Closed
Goldman Sachs
40
Goldman Sachs
New York
– -$1.1M -27,267 Closed
HM
41
Harvest Management
New York
– -$1.01M -25,000 Closed
JP Morgan Chase
42
JP Morgan Chase
New York
– -$999K -24,834 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
– -$718K -17,860 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$694K -17,246 Closed
PCM
45
Prelude Capital Management
New York
– -$497K -12,352 Closed
WAM
46
Wolverine Asset Management
Illinois
– -$490K -12,200 Closed
UBS Group
47
UBS Group
Switzerland
– -$460K -11,437 Closed
HCMT
48
Highland Capital Management (Texas)
Texas
– -$400K -9,950 Closed
KIA
49
Kopp Investment Advisors
Minnesota
– -$296K -7,359 Closed
NIM
50
Northeast Investment Management
Massachusetts
– -$282K -7,000 Closed
1
2
3

CYNA Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q4 2016, worth a combined $0 — down 100% from $348M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of CYNA and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Aisling Capital, exiting entirely with an estimated $45.1M sold.

  • 0 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q4 2016, down from 60 in Q3 2016.
  • Funds reported $0 of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q4 2016 and 60 closed out, a net change of -60 holders.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q4 2016 was Aisling Capital, an estimated $45.1M sold.

Based on aggregated 13F filings for Q4 2016.